VAP Facts

Ventilator-associated Pneumonia (VAP) is the second most common nosocomial infection in the United States resulting in negative patient outcomes and increased healthcare costs.1

  • VAP is estimated to occur in 9-25% of all ICU patients alone (Ref. 2-4)
  • VAP is a costly complication of hospitalization that lengthens ICU and hospital stay and increases morbidity and mortality (Ref. 5)
  • Mortality that is directly attributable to VAP is estimated to be as high as 27% (Ref. 6,10,25)
  • VAP is associated with more than $40,000 in increased hospital costs per patient and may be higher in certain types of patient care units (Ref. 5)
  • Current commonly used modalities of treatment involve recumbent positioning, oral hygiene, and some form of aspiration typically performed by nurses through use of a simple syringe and in some facilities by nurses attaching the patient’s tracheal or endotracheal tube suction port to either wall suction or portable (multi-purpose) suction devices (Ref. 8-9,16,19-20,25)
  • Emerging research indicates that aspiration of subglottic secretions and specifically the intermittent aspiration of subglottic secretions is extremely helpful in the reduction of the incidence of VAP (Ref. 18-20,25,36-39)